GE HealthCare (NASDAQ: GEHC) reported Q3 EPS of $0.99, $0.10 better than the analyst estimate of $0.89. Revenue for the quarter came in at $4.8 billion versus the consensus estimate of $4.81 billion.

GUIDANCE:

GE HealthCare sees FY2023 EPS of $3.75-$3.85, versus prior guidance of $3.70-$3.85 and the consensus of $3.80. Organic revenue growth* in the range of 6% to 8% year-over-year.

For earnings history and earnings-related data on GE HealthCare (GEHC) click here.